Arcaea
Other Pharmaceuticals and Biotechnology
Arcaea valuation and funding history | Last updated: October 28, 2021 | 1 funding rounds
Current Valuation
N/A
As of October 28, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$78.0M
Last Funding
Oct 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 28, 2021 | Early Stage VC (Series A) | $78.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Arcaea is currently valued at N/A as of October 28, 2021.
What is Arcaea Worth in 2026?
Arcaea is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Arcaea's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Arcaea Valuation is Determined
Private company valuations like Arcaea's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.